Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Stoke Therapeutics Inc (STOK)

Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 704,155
  • Shares Outstanding, K 52,121
  • Annual Sales, $ 8,780 K
  • Annual Income, $ -104,700 K
  • 60-Month Beta 0.88
  • Price/Sales 79.01
  • Price/Cash Flow N/A
  • Price/Book 4.94
Trade STOK with:

Options Overview Details

View History
  • Implied Volatility 91.12% ( -1.36%)
  • Historical Volatility 79.47%
  • IV Percentile 36%
  • IV Rank 15.33%
  • IV High 312.96% on 07/14/23
  • IV Low 50.95% on 11/13/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 793
  • Open Int (30-Day) 1,230

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.55
  • Number of Estimates 5
  • High Estimate -0.45
  • Low Estimate -0.63
  • Prior Year -0.69
  • Growth Rate Est. (year over year) +20.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.76 +5.88%
on 06/27/24
17.58 -23.15%
on 06/13/24
-0.55 (-3.95%)
since 05/28/24
3-Month
10.90 +23.94%
on 04/22/24
17.58 -23.15%
on 06/13/24
+0.01 (+0.07%)
since 03/28/24
52-Week
3.35 +303.28%
on 10/27/23
17.58 -23.15%
on 06/13/24
+2.52 (+22.93%)
since 06/28/23

Business Summary

Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company's product candidate consists of STK-001 which is to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics Inc. is based in Bedford,...

See More

Key Turning Points

3rd Resistance Point 14.66
2nd Resistance Point 14.17
1st Resistance Point 13.84
Last Price 13.51
1st Support Level 13.02
2nd Support Level 12.53
3rd Support Level 12.20

See More

52-Week High 17.58
Last Price 13.51
Fibonacci 61.8% 12.14
Fibonacci 50% 10.47
Fibonacci 38.2% 8.79
52-Week Low 3.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar